1. Lee, Y. C.; Wang, J. H.; Huang, T. L.; Tsai, R. K., Increased Risk of Stroke in Patients With Nonarteritic Anterior Ischemic Optic Neuropathy: A Nationwide Retrospective Cohort Study. American journal of ophthalmology 2016, 170, 183-189.
2. Bernstein, S. L.; Johnson, M. A.; Miller, N. R., Nonarteritic anterior ischemic optic neuropathy (NAION) and its experimental models. Progress in retinal and eye research 2011, 30, (3), 167-87.
3. Yang, Y.; Xu, C.; Chen, Y.; Liang, J. J.; Xu, Y.; Chen, S. L.; Huang, S.; Yang, Q.; Cen, L. P.; Pang, C. P.; Sun, X. H.; Ng, T. K., Green Tea Extract Ameliorates Ischemia-Induced Retinal Ganglion Cell Degeneration in Rats. Oxidative medicine and cellular longevity 2019, 2019, 8407206.
4. Park, J. W.; Sung, M. S.; Ha, J. Y.; Guo, Y.; Piao, H.; Heo, H.; Park, S. W., Neuroprotective Effect of Brazilian Green Propolis on Retinal Ganglion Cells in Ischemic Mouse Retina. Current eye research 2020, 45, (8), 955-964.
5. Lin, W. N.; Kapupara, K.; Wen, Y. T.; Chen, Y. H.; Pan, I. H.; Tsai, R. K., Haematococcus pluvialis-Derived Astaxanthin Is a Potential Neuroprotective Agent against Optic Nerve Ischemia. Marine drugs 2020, 18, (2).
6. Guan, L.; Li, C.; Zhang, Y.; Gong, J.; Wang, G.; Tian, P.; Shen, N., Puerarin ameliorates retinal ganglion cell damage induced by retinal ischemia/reperfusion through inhibiting the activation of TLR4/NLRP3 inflammasome. Life sciences 2020, 256, 117935.
7. Wen, Y. T.; Huang, T. L.; Huang, S. P.; Chang, C. H.; Tsai, R. K., Early applications of granulocyte colony-stimulating factor (G-CSF) can stabilize the blood-optic-nerve barrier and ameliorate inflammation in a rat model of anterior ischemic optic neuropathy (rAION). Dis Model Mech 2016, 9, (10), 1193-1202.
8. Melamed, S., Neuroprotective properties of a synthetic docosanoid, unoprostone isopropyl: clinical benefits in the treatment of glaucoma. Drugs under experimental and clinical research 2002, 28, (2-3), 63-73.
9. Georgiou, T.; Wen, Y. T.; Chang, C. H.; Kolovos, P.; Kalogerou, M.; Prokopiou, E.; Neokleous, A.; Huang, C. T.; Tsai, R. K., Neuroprotective Effects of Omega-3 Polyunsaturated Fatty Acids in a Rat Model of Anterior Ischemic Optic Neuropathy. Invest Ophthalmol Vis Sci 2017, 58, (3), 1603-1611.
10. Nguyen Ngo Le, M. A.; Wen, Y. T.; Ho, Y. C.; Kapupara, K.; Tsai, R. K., Therapeutic Effects of Puerarin Against Anterior Ischemic Optic Neuropathy Through Antiapoptotic and Anti-Inflammatory Actions. Invest Ophthalmol Vis Sci 2019, 60, (10), 3481-3491.
11. Huang, T. L.; Wen, Y. T.; Chang, C. H.; Chang, S. W.; Lin, K. H.; Tsai, R. K., Early Methylprednisolone Treatment Can Stabilize the Blood-Optic Nerve Barrier in a Rat Model of Anterior Ischemic Optic Neuropathy (rAION). Invest Ophthalmol Vis Sci 2017, 58, (3), 1628-1636.
12. Kapupara, K.; Wen, Y. T.; Tsai, R. K.; Huang, S. P., Soluble P-selectin promotes retinal ganglion cell survival through activation of Nrf2 signaling after ischemia injury. Cell death & disease 2017, 8, (11), e3172.
13. Goldenberg-Cohen, N.; Avraham-Lubin, B. C.; Sadikov, T.; Askenasy, N., Effect of coadministration of neuronal growth factors on neuroglial differentiation of bone marrow-derived stem cells in the ischemic retina. Invest Ophthalmol Vis Sci 2014, 55, (1), 502-12.
14. Ribas, V. T.; Koch, J. C.; Michel, U.; Bähr, M.; Lingor, P., Attenuation of Axonal Degeneration by Calcium Channel Inhibitors Improves Retinal Ganglion Cell Survival and Regeneration After Optic Nerve Crush. Mol Neurobiol 2017, 54, (1), 72-86.
15. Mehrabian, Z.; Guo, Y.; Weinreich, D.; Bernstein, S. L., Oligodendrocyte death, neuroinflammation, and the effects of minocycline in a rodent model of nonarteritic anterior ischemic optic neuropathy (rNAION). Molecular vision 2017, 23, 963-976.
16. Huang, T. L.; Wen, Y. T.; Chang, C. H.; Chang, S. W.; Lin, K. H.; Tsai, R. K., Efficacy of Intravitreal Injections of Triamcinolone Acetonide in a Rodent Model of Nonarteritic Anterior Ischemic Optic Neuropathy. Invest Ophthalmol Vis Sci 2016, 57, (4), 1878-84.
17. Tsai, R. K.; Chang, C. H.; Sheu, M. M.; Huang, Z. L., Anti-apoptotic effects of human granulocyte colony-stimulating factor (G-CSF) on retinal ganglion cells after optic nerve crush are PI3K/AKT-dependent. Exp Eye Res 2010, 90, (5), 537-45.
18. Ghalaut, P. S.; Sen, R.; Dixit, G., Role of granulocyte colony stimulating factor (G-CSF) in chemotherapy induced neutropenia. The Journal of the Association of Physicians of India 2008, 56, 942-4.
19. Ghahari, L.; Safari, M.; Rahimi Jaberi, K.; Jafari, B.; Safari, K.; Madadian, M., Mesenchymal Stem Cells with Granulocyte Colony-Stimulating Factor Reduce Stress Oxidative Factors in Parkinson's Disease. Iranian biomedical journal 2020, 24, (2), 89-98.
20. Wu, C. C.; Wang, I. F.; Chiang, P. M.; Wang, L. C.; Shen, C. J.; Tsai, K. J., G-CSF-mobilized Bone Marrow Mesenchymal Stem Cells Replenish Neural Lineages in Alzheimer's Disease Mice via CXCR4/SDF-1 Chemotaxis. Mol Neurobiol 2017, 54, (8), 6198-6212.
21. Lee, S. T.; Chu, K.; Jung, K. H.; Ko, S. Y.; Kim, E. H.; Sinn, D. I.; Lee, Y. S.; Lo, E. H.; Kim, M.; Roh, J. K., Granulocyte colony-stimulating factor enhances angiogenesis after focal cerebral ischemia. Brain Res 2005, 1058, (1-2), 120-8.
22. Bu, P.; Basith, B.; Stubbs, E. B., Jr.; Perlman, J. I., Granulocyte colony-stimulating factor facilitates recovery of retinal function following retinal ischemic injury. Exp Eye Res 2010, 91, (1), 104-6.
23. Popa-Wagner, A.; Stocker, K.; Balseanu, A. T.; Rogalewski, A.; Diederich, K.; Minnerup, J.; Margaritescu, C.; Schabitz, W. R., Effects of granulocyte-colony stimulating factor after stroke in aged rats. Stroke; a journal of cerebral circulation 2010, 41, (5), 1027-31.
24. Dwivedi, P.; Greis, K. D., Granulocyte colony-stimulating factor receptor signaling in severe congenital neutropenia, chronic neutrophilic leukemia, and related malignancies. Experimental hematology 2017, 46, 9-20.
25. Laboissonniere, L. A.; Goetz, J. J.; Martin, G. M.; Bi, R.; Lund, T. J. S.; Ellson, L.; Lynch, M. R.; Mooney, B.; Wickham, H.; Liu, P.; Schwartz, G. W.; Trimarchi, J. M., Molecular signatures of retinal ganglion cells revealed through single cell profiling. Sci Rep 2019, 9, (1), 15778.
26. Ueno, S.; Yoneshige, A.; Koriyama, Y.; Hagiyama, M.; Shimomura, Y.; Ito, A., Early Gene Expression Profile in Retinal Ganglion Cell Layer After Optic Nerve Crush in Mice. Invest Ophthalmol Vis Sci 2018, 59, (1), 370-380.
27. Bernstein, S. L.; Guo, Y.; Kelman, S. E.; Flower, R. W.; Johnson, M. A., Functional and cellular responses in a novel rodent model of anterior ischemic optic neuropathy. Invest Ophthalmol Vis Sci 2003, 44, (10), 4153-62.
28. Buschmann, T.; Lin, Y.; Aithmitti, N.; Fuchs, S. Y.; Lu, H.; Resnick-Silverman, L.; Manfredi, J. J.; Ronai, Z.; Wu, X., Stabilization and activation of p53 by the coactivator protein TAFII31. The Journal of biological chemistry 2001, 276, (17), 13852-7.
29. Uesugi, M.; Nyanguile, O.; Lu, H.; Levine, A. J.; Verdine, G. L., Induced alpha helix in the VP16 activation domain upon binding to a human TAF. Science (New York, N.Y.) 1997, 277, (5330), 1310-3.
30. Jabbur, J. R.; Tabor, A. D.; Cheng, X.; Wang, H.; Uesugi, M.; Lozano, G.; Zhang, W., Mdm-2 binding and TAF(II)31 recruitment is regulated by hydrogen bond disruption between the p53 residues Thr18 and Asp21. Oncogene 2002, 21, (46), 7100-13.
31. Frontini, M.; Soutoglou, E.; Argentini, M.; Bole-Feysot, C.; Jost, B.; Scheer, E.; Tora, L., TAF9b (formerly TAF9L) is a bona fide TAF that has unique and overlapping roles with TAF9. Molecular and cellular biology 2005, 25, (11), 4638-49.
32. Fook-Alves, V. L.; de Oliveira, M. B.; Zanatta, D. B.; Strauss, B. E.; Colleoni, G. W., TP53 Regulated Inhibitor of Apoptosis 1 (TRIAP1) stable silencing increases late apoptosis by upregulation of caspase 9 and APAF1 in RPMI8226 multiple myeloma cell line. Biochimica et biophysica acta 2016, 1862, (6), 1105-10.
33. Bosco-Clément, G.; Zhang, F.; Chen, Z.; Zhou, H. M.; Li, H.; Mikami, I.; Hirata, T.; Yagui-Beltran, A.; Lui, N.; Do, H. T.; Cheng, T.; Tseng, H. H.; Choi, H.; Fang, L. T.; Kim, I. J.; Yue, D.; Wang, C.; Zheng, Q.; Fujii, N.; Mann, M.; Jablons, D. M.; He, B., Targeting Gli transcription activation by small molecule suppresses tumor growth. Oncogene 2014, 33, (16), 2087-97.
34. Huang, T. L.; Huang, S. P.; Chang, C. H.; Lin, K. H.; Chang, S. W.; Tsai, R. K., Protective effects of systemic treatment with methylprednisolone in a rodent model of non-arteritic anterior ischemic optic neuropathy (rAION). Exp Eye Res 2015, 131, 69-76.
35. Hampsey, M., Molecular genetics of the RNA polymerase II general transcriptional machinery. Microbiology and molecular biology reviews : MMBR 1998, 62, (2), 465-503.
36. Huh, J. R.; Park, J. M.; Kim, M.; Carlson, B. A.; Hatfield, D. L.; Lee, B. J., Recruitment of TBP or TFIIB to a promoter proximal position leads to stimulation of RNA polymerase II transcription without activator proteins both in vivo and in vitro. Biochemical and biophysical research communications 1999, 256, (1), 45-51.
37. Wu, S. Y.; Chiang, C. M., TATA-binding protein-associated factors enhance the recruitment of RNA polymerase II by transcriptional activators. The Journal of biological chemistry 2001, 276, (36), 34235-43.
38. Klaus, E. S.; Gonzalez, N. H.; Bergmann, M.; Bartkuhn, M.; Weidner, W.; Kliesch, S.; Rathke, C., Murine and Human Spermatids Are Characterized by Numerous, Newly Synthesized and Differentially Expressed Transcription Factors and Bromodomain-Containing Proteins. Biology of reproduction 2016, 95, (1), 4.
39. Deato, M. D.; Marr, M. T.; Sottero, T.; Inouye, C.; Hu, P.; Tjian, R., MyoD targets TAF3/TRF3 to activate myogenin transcription. Molecular cell 2008, 32, (1), 96-105.
40. Deato, M. D.; Tjian, R., Switching of the core transcription machinery during myogenesis. Genes & development 2007, 21, (17), 2137-49.
41. Deato, M. D.; Tjian, R., An unexpected role of TAFs and TRFs in skeletal muscle differentiation: switching core promoter complexes. Cold Spring Harbor symposia on quantitative biology 2008, 73, 217-25.
42. Dikstein, R.; Zhou, S.; Tjian, R., Human TAFII 105 is a cell type-specific TFIID subunit related to hTAFII130. Cell 1996, 87, (1), 137-46.
43. Martianov, I.; Brancorsini, S.; Gansmuller, A.; Parvinen, M.; Davidson, I.; Sassone-Corsi, P., Distinct functions of TBP and TLF/TRF2 during spermatogenesis: requirement of TLF for heterochromatic chromocenter formation in haploid round spermatids. Development (Cambridge, England) 2002, 129, (4), 945-55.
44. Ribeiro, J. R.; Lovasco, L. A.; Vanderhyden, B. C.; Freiman, R. N., Targeting TBP-Associated Factors in Ovarian Cancer. Frontiers in oncology 2014, 4, 45.
45. Bell, B.; Scheer, E.; Tora, L., Identification of hTAF(II)80 delta links apoptotic signaling pathways to transcription factor TFIID function. Molecular cell 2001, 8, (3), 591-600.
46. Resnick, M. A.; Tomso, D.; Inga, A.; Menendez, D.; Bell, D., Functional diversity in the gene network controlled by the master regulator p53 in humans. Cell cycle (Georgetown, Tex.) 2005, 4, (8), 1026-9.
47. Adams, C.; Cazzanelli, G.; Rasul, S.; Hitchinson, B.; Hu, Y.; Coombes, R. C.; Raguz, S.; Yagüe, E., Apoptosis inhibitor TRIAP1 is a novel effector of drug resistance. Oncology reports 2015, 34, (1), 415-22.
48. Staib, F.; Robles, A. I.; Varticovski, L.; Wang, X. W.; Zeeberg, B. R.; Sirotin, M.; Zhurkin, V. B.; Hofseth, L. J.; Hussain, S. P.; Weinstein, J. N.; Galle, P. R.; Harris, C. C., The p53 tumor suppressor network is a key responder to microenvironmental components of chronic inflammatory stress. Cancer research 2005, 65, (22), 10255-64.
49. Andrysik, Z.; Kim, J.; Tan, A. C.; Espinosa, J. M., A genetic screen identifies TCF3/E2A and TRIAP1 as pathway-specific regulators of the cellular response to p53 activation. Cell reports 2013, 3, (5), 1346-54.
50. Potting, C.; Tatsuta, T.; König, T.; Haag, M.; Wai, T.; Aaltonen, M. J.; Langer, T., TRIAP1/PRELI complexes prevent apoptosis by mediating intramitochondrial transport of phosphatidic acid. Cell metabolism 2013, 18, (2), 287-95.
51. Miliara, X.; Garnett, J. A.; Tatsuta, T.; Abid Ali, F.; Baldie, H.; Pérez-Dorado, I.; Simpson, P.; Yague, E.; Langer, T.; Matthews, S., Structural insight into the TRIAP1/PRELI-like domain family of mitochondrial phospholipid transfer complexes. EMBO reports 2015, 16, (7), 824-35.
52. Liu, P. K.; Wen, Y. T.; Lin, W.; Kapupara, K.; Tai, M.; Tsai, R. K., Neuroprotective effects of low-dose G-CSF plus meloxicam in a rat model of anterior ischemic optic neuropathy. Sci Rep 2020, 10, (1), 10351.